Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Health/BeautyCosmetic Goods

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410555

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1410555

Dermacosmetics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global dermacosmetics market is set to experience substantial growth over the next decade, according to a recent market analysis. In 2024, the market was valued at US$ 19 billion, and it is projected to maintain a steady growth, ultimately reaching a market value of US$ 25 billion by the end of 2031.

Innovative Product Adoption - Microbiome in Dermacosmetics

One of the key driving forces behind this growth is the continued focus on the microbiome within the dermacosmetics industry. Manufacturers are increasingly incorporating probiotics and prebiotics, traditionally known for aiding digestion, into their products to promote preventive skin health.

Probiotics contain live, beneficial bacteria that enhance the body's natural ability to maintain healthy and intact skin, while prebiotics encourage the growth of specific bacteria, including beneficial strains. This innovative approach is not only gaining traction in skincare but also extending its potential to areas like oral and hair care.

The most promising applications for the microbiome in dermacosmetics include post-biotics, anti-aging products, and acne treatments. To unlock the full potential of this concept, ongoing research and customization are essential, along with the adaptation to evolving regulatory requirements for microbiome products.

Customization and Rx-formulated Products

Manufacturers are responding to the demand for personalized skincare by offering an expanded range of Rx-formulated products, particularly in the topical acne treatment sector. Customers are increasingly rejecting the 'one size fits all' approach, prompting companies to develop multiple variants of products tailored to different skin types, weather conditions, and ingredient strengths. This trend towards customization is expected to drive product innovation and market expansion.

Challenges and Opportunities

While the dermacosmetics market holds significant growth potential, there are challenges to be addressed. The lack of long-term data on product efficacy has been noted by the American Academy of Dermatology (AAD), which can lead to discontinuation in product usage and hinder research and development efforts. Additionally, the lack of awareness about dermacosmetics could negatively impact market growth, as new users may use products without seeking professional advice, potentially causing harm.

Country-wise Insights

  • U.S. Market: The U.S. market is being driven by a high prevalence of skin disorders among various age groups. Dermacosmetic product approvals have further fueled the demand, as these products help address skin issues and improve confidence.
  • Germany: Germany remains a major manufacturer of dermacosmetics in Europe, with the growth of online media contributing to product awareness. Blogs, social media, and review platforms are playing a crucial role in informing and influencing consumer choices, driving demand.
  • Japan: The rising number of dermatology clinics in Japan is boosting the demand for prescription products, particularly for acne treatment. Effective yet well-tolerated treatment regimes are becoming essential, and well-trained dermatologists play a critical role in fueling market growth.
  • India: Rapid urbanization in India, coupled with environmental pollution, is leading to a rising incidence of skin disorders. This is expected to drive the demand for dermacosmetics as individuals seek solutions for skin issues.

Competitive Landscape

Leading dermacosmetic manufacturers worldwide are actively developing innovative solutions and engaging in collaborations to strengthen their product lines. Several major competitors in the industry have undertaken consolidation activities to expedite research and development efforts.

Key Companies Profiled:

  • Merck KGaA
  • L'Oreal Group
  • Oxytical
  • Cipla Inc.
  • Pierre Fabre group
  • Johnson & Johnson
  • NAOS
  • Puig
  • Swisskem Healthcare
  • Kuora Dermo Cosmetics
  • Politech
  • CeraVe
  • GALDERMA LABORATORIES, L.P.
  • BEIERSDORF
  • Bausch Health Companies Inc.
  • Ultimate Skin Aesthetics GmbH
  • Procter & Gamble
  • Unilever
  • Coty
  • Colgate-Palmolive

Segments of Dermacosmetics Industry Research

By Treatment:

  • Skin Care
  • Hair Care
  • Anti-aging
  • Hygiene
  • Sun Care
  • Cosmetics
  • Facial care
  • Others

By Indication:

  • Dry Skin
  • Atopic Skin Eczema
  • Hyperpigmentation
  • Scar & Acne
  • Psoriasis
  • Deep Wrinkles
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce stores
  • Hypermarkets & Supermarkets
  • Speciality Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Dermacosmetics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Dermacosmetics Market Outlook, 2018 - 2031

  • 3.1. Global Dermacosmetics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Skin Care
      • 3.1.1.2. Hair Care
      • 3.1.1.3. Anti-aging
      • 3.1.1.4. Hygiene
      • 3.1.1.5. Sun Care
      • 3.1.1.6. Cosmetics
      • 3.1.1.7. Facial care
      • 3.1.1.8. Others
  • 3.2. Global Dermacosmetics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Dry Skin
      • 3.2.1.2. Atopic Skin Eczema
      • 3.2.1.3. Hyperpigmentation
      • 3.2.1.4. Scar & Acne
      • 3.2.1.5. Psoriasis
      • 3.2.1.6. Deep Wrinkles
      • 3.2.1.7. Others
  • 3.3. Global Dermacosmetics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospital Pharmacies
      • 3.3.1.2. Retail Pharmacies
      • 3.3.1.3. E-commerce stores
      • 3.3.1.4. Hypermarkets & Supermarkets
      • 3.3.1.5. Speciality Clinics
  • 3.4. Global Dermacosmetics Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Dermacosmetics Market Outlook, 2018 - 2031

  • 4.1. North America Dermacosmetics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Skin Care
      • 4.1.1.2. Hair Care
      • 4.1.1.3. Anti-aging
      • 4.1.1.4. Hygiene
      • 4.1.1.5. Sun Care
      • 4.1.1.6. Cosmetics
      • 4.1.1.7. Facial care
      • 4.1.1.8. Others
  • 4.2. North America Dermacosmetics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dry Skin
      • 4.2.1.2. Atopic Skin Eczema
      • 4.2.1.3. Hyperpigmentation
      • 4.2.1.4. Scar & Acne
      • 4.2.1.5. Psoriasis
      • 4.2.1.6. Deep Wrinkles
      • 4.2.1.7. Others
  • 4.3. North America Dermacosmetics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospital Pharmacies
      • 4.3.1.2. Retail Pharmacies
      • 4.3.1.3. E-commerce stores
      • 4.3.1.4. Hypermarkets & Supermarkets
      • 4.3.1.5. Speciality Clinics
  • 4.4. North America Dermacosmetics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Dermacosmetics Market Outlook, 2018 - 2031

  • 5.1. Europe Dermacosmetics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Skin Care
      • 5.1.1.2. Hair Care
      • 5.1.1.3. Anti-aging
      • 5.1.1.4. Hygiene
      • 5.1.1.5. Sun Care
      • 5.1.1.6. Cosmetics
      • 5.1.1.7. Facial care
      • 5.1.1.8. Others
  • 5.2. Europe `Dermacosmetics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dry Skin
      • 5.2.1.2. Atopic Skin Eczema
      • 5.2.1.3. Hyperpigmentation
      • 5.2.1.4. Scar & Acne
      • 5.2.1.5. Psoriasis
      • 5.2.1.6. Deep Wrinkles
      • 5.2.1.7. Others
  • 5.3. Europe Dermacosmetics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospital Pharmacies
      • 5.3.1.2. Retail Pharmacies
      • 5.3.1.3. E-commerce stores
      • 5.3.1.4. Hypermarkets & Supermarkets
      • 5.3.1.5. Speciality Clinics
  • 5.4. Europe Dermacosmetics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dermacosmetics Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Dermacosmetics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Skin Care
      • 6.1.1.2. Hair Care
      • 6.1.1.3. Anti-aging
      • 6.1.1.4. Hygiene
      • 6.1.1.5. Sun Care
      • 6.1.1.6. Cosmetics
      • 6.1.1.7. Facial care
      • 6.1.1.8. Others
  • 6.2. Asia Pacific Dermacosmetics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dry Skin
      • 6.2.1.2. Atopic Skin Eczema
      • 6.2.1.3. Hyperpigmentation
      • 6.2.1.4. Scar & Acne
      • 6.2.1.5. Psoriasis
      • 6.2.1.6. Deep Wrinkles
      • 6.2.1.7. Others
  • 6.3. Asia Pacific Dermacosmetics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospital Pharmacies
      • 6.3.1.2. Retail Pharmacies
      • 6.3.1.3. E-commerce stores
      • 6.3.1.4. Hypermarkets & Supermarkets
      • 6.3.1.5. Speciality Clinics
  • 6.4. Asia Pacific Dermacosmetics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dermacosmetics Market Outlook, 2018 - 2031

  • 7.1. Latin America Dermacosmetics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Skin Care
      • 7.1.1.2. Hair Care
      • 7.1.1.3. Anti-aging
      • 7.1.1.4. Hygiene
      • 7.1.1.5. Sun Care
      • 7.1.1.6. Cosmetics
      • 7.1.1.7. Facial care
      • 7.1.1.8. Others
  • 7.2. Latin America Dermacosmetics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dry Skin
      • 7.2.1.2. Atopic Skin Eczema
      • 7.2.1.3. Hyperpigmentation
      • 7.2.1.4. Scar & Acne
      • 7.2.1.5. Psoriasis
      • 7.2.1.6. Deep Wrinkles
      • 7.2.1.7. Others
  • 7.3. Latin America Dermacosmetics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospital Pharmacies
      • 7.3.1.2. Retail Pharmacies
      • 7.3.1.3. E-commerce stores
      • 7.3.1.4. Hypermarkets & Supermarkets
      • 7.3.1.5. Speciality Clinics
  • 7.4. Latin America Dermacosmetics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dermacosmetics Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Dermacosmetics Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Skin Care
      • 8.1.1.2. Hair Care
      • 8.1.1.3. Anti-aging
      • 8.1.1.4. Hygiene
      • 8.1.1.5. Sun Care
      • 8.1.1.6. Cosmetics
      • 8.1.1.7. Facial care
      • 8.1.1.8. Others
  • 8.2. Middle East & Africa Dermacosmetics Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dry Skin
      • 8.2.1.2. Atopic Skin Eczema
      • 8.2.1.3. Hyperpigmentation
      • 8.2.1.4. Scar & Acne
      • 8.2.1.5. Psoriasis
      • 8.2.1.6. Deep Wrinkles
      • 8.2.1.7. Others
  • 8.3. Middle East & Africa Dermacosmetics Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospital Pharmacies
      • 8.3.1.2. Retail Pharmacies
      • 8.3.1.3. E-commerce stores
      • 8.3.1.4. Hypermarkets & Supermarkets
      • 8.3.1.5. Speciality Clinics
  • 8.4. Middle East & Africa Dermacosmetics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Dermacosmetics Market by Treatment, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Dermacosmetics Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Dermacosmetics Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Treatment vs Indication Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Merck KGaA
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. L'Oreal Group
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Oxytical
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Cipla Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Pierre Fabre group
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Johnson & Johnson
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. NAOS
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Puig
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Swisskem Healthcare.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Kuora Dermo Cosmetics
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Politech
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. CeraVe
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. GALDERMA LABORATORIES, L.P.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. BEIERSDORF
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Bausch Health Companies Inc.
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development
    • 9.4.16. Ultimate Skin Aesthetics GmbH
      • 9.4.16.1. Company Overview
      • 9.4.16.2. Product Portfolio
      • 9.4.16.3. Financial Overview
      • 9.4.16.4. Business Strategies and Development
    • 9.4.17. Procter & Gamble
      • 9.4.17.1. Company Overview
      • 9.4.17.2. Product Portfolio
      • 9.4.17.3. Financial Overview
      • 9.4.17.4. Business Strategies and Development
    • 9.4.18. Unilever
      • 9.4.18.1. Company Overview
      • 9.4.18.2. Product Portfolio
      • 9.4.18.3. Financial Overview
      • 9.4.18.4. Business Strategies and Development
    • 9.4.19. Coty
      • 9.4.19.1. Company Overview
      • 9.4.19.2. Product Portfolio
      • 9.4.19.3. Financial Overview
      • 9.4.19.4. Business Strategies and Development
    • 9.4.20. Colgate-Palmolive
      • 9.4.20.1. Company Overview
      • 9.4.20.2. Product Portfolio
      • 9.4.20.3. Financial Overview
      • 9.4.20.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!